Progesterone Inhibits Human Myometrial Contractions by its Action on Membrane Receptors
dc.contributor.author | Gokdeniz, Remzi | |
dc.contributor.author | Ovayolu, Ali | |
dc.contributor.author | Garfield, Robert E. | |
dc.date.accessioned | 2024-08-04T21:00:55Z | |
dc.date.available | 2024-08-04T21:00:55Z | |
dc.date.issued | 2013 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Purpose: The mechanisms for myometrial inhibition are still being investigated. The aim of this article is to examine mechanisms of progesterone (P4) inhibition of uterine contractility. Methods: Prospective study Tertiary care center at St. Joseph's Hospital and at Maricopa Hospital, Phoenix, AZ and research center in Arizona, USA. During 2010-2011 24 women were given birth by cesarean section. Uterine tissues from women (n= 24) at term were suspended in organ chambers and exposed to various agents. Contractility was recorded and compared before and after addition of agents. Tissues were treated with P4 alone, a progestin (R5020) with low affinity to the progesterone membrane receptor (mPR), or a non-sex steroid (cholesterol). Other tissues were pretreated with inhibitors of adenylate cyclase (SQ 22536), phosphodiesterase (rolipram), nitric oxide ( NO) synthases (L-NAME) or a nuclear P4 receptor antagonist (mifepristone, MIF), followed by P4. Data were analyzed by ANOVA. Results: P4 (P< 0.05) inhibits uterine contractions. R5020 and cholesterol have little P> 0.05) inhibitory effects. P4 inhibition is not blocked by MIF, SQ, ODQ, rolipram or L-NAME ( P> 0.05). Conclusions: P4 rapidly inhibits myometrial contractility by nongenomic mechanisms through action on mPR but not via cAMP, cGMP, or NO | en_US |
dc.description.sponsorship | St. Joseph's Research Foundation | en_US |
dc.description.sponsorship | Funding for this study was supported by the St. Joseph's Research Foundation: see above under Acknowledgements. | en_US |
dc.identifier.endpage | 102 | en_US |
dc.identifier.issn | 2602-3032 | |
dc.identifier.issn | 2602-3040 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 92 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/103924 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000216438000012 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cukurova Univ, Fac Medicine | en_US |
dc.relation.ispartof | Cukurova Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cyclic adenosine monophosphate | en_US |
dc.subject | myometrium | en_US |
dc.subject | preterm labor | en_US |
dc.subject | progesterone receptors | en_US |
dc.subject | uterine contractility | en_US |
dc.title | Progesterone Inhibits Human Myometrial Contractions by its Action on Membrane Receptors | en_US |
dc.type | Article | en_US |